Ngā hua rapu - Atul Mehta

Whakamahine hua
  1. 1
    Glucose-6-phosphate dehydrogenase deficiency

    Glucose-6-phosphate dehydrogenase deficiency mā Atul Mehta

    I whakaputaina 1994
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Gaucher disease: haematological presentations and complications

    Gaucher disease: haematological presentations and complications mā Alison Thomas, Atul Mehta, Derralynn Hughes

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    How we manage Gaucher Disease in the era of choices

    How we manage Gaucher Disease in the era of choices mā Shoshana Revel‐Vilk, Jeff Szer, Atul Mehta, Ari Zimran

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpura

    Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpura mā Jo Howard, A. V. Hoffbrand, H. G. Prentice, Atul Mehta

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    A clinical and family history study of Parkinson's disease in heterozygous<i>glucocerebrosidase</i>mutation carriers

    A clinical and family history study of Parkinson's disease in heterozygous<i>glucocerebrosidase</i>mutation carriers mā Alisdair McNeill, Raquel Durán, Derralynn Hughes, Atul Mehta, Anthony H.V. Schapira

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation

    Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation mā John Goulis, T N Chau, S Jordan, Atul Mehta, A. Watkinson, Keith Rolles, Andrew K. Burroughs

    I whakaputaina 1999
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Evolution of Prodromal Clinical Markers of Parkinson Disease in a<i>GBA</i>Mutation–Positive Cohort

    Evolution of Prodromal Clinical Markers of Parkinson Disease in a<i>GBA</i>Mutation–Positive Cohort mā Michelle Beavan, Alisdair McNeill, Christos Proukakis, Derralynn Hughes, Atul Mehta, Anthony H.V. Schapira

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey

    Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey mā Aleš Linhart, Christoph Kampmann, José Luis Zamorano, Gere Sunder‐Plassmann, Michael Beck, Atul Mehta, Perry Elliott

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Clinical prodromes of neurodegeneration in Anderson-Fabry disease

    Clinical prodromes of neurodegeneration in Anderson-Fabry disease mā Matthias Löhle, Derralynn Hughes, Alan Milligan, Linda Richfield, Heinz Reichmann, Atul Mehta, Anthony H.V. Schapira

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    The Binary Endocardial Appearance Is a Poor Discriminator of Anderson-Fabry Disease From Familial Hypertrophic Cardiomyopathy

    The Binary Endocardial Appearance Is a Poor Discriminator of Anderson-Fabry Disease From Familial Hypertrophic Cardiomyopathy mā Stavros P. Kounas, Camelia Demetrescu, Antonios Pantazis, Andre Keren, Philip Lee, Derralynn Hughes, Atul Mehta, Perry Elliott

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey

    Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey mā Atul Mehta, Joe T.R. Clarke, Roberto Giugliani, Perry Elliott, Aleš Linhart, Michael Beck, Gere Sunder‐Plassmann

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia

    Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia mā Dario Campana, JJ van Dongen, Atul Mehta, Elaine Coustan‐Smith, IL Wolvers-Tettero, K. Ganeshaguru, George Janossy

    I whakaputaina 1991
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation

    Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation mā Lucia Lavalle, A. Thomas, Brendan Beaton, H. Ebrahim, Malcolm Reed, Uma Ramaswami, Perry Elliott, Atul Mehta, Derralynn Hughes

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide

    A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide mā Atul Mehta, Uma Ramaswami, Joseph Muenzer, Roberto Giugliani, Kurt Ullrich, Tanya Collin-Histed, Zoya Panahloo, Hartmann Wellhoefer, Joel Frader

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Fabry disease: a review of current management strategies

    Fabry disease: a review of current management strategies mā Atul Mehta, Michael Beck, F. Eyskens, Claudio Feliciani, Ilkka Kantola, Uma Ramaswami, A. Rolfs, A. Rivera, S. Waldek, Dominique P. Germain

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Gaucher Cells Demonstrate a Distinct Macrophage Phenotype and Resemble Alternatively Activated Macrophages

    Gaucher Cells Demonstrate a Distinct Macrophage Phenotype and Resemble Alternatively Activated Macrophages mā Leonie A. Boven, Marjan van Meurs, Rolf G. Boot, Atul Mehta, Louis Boon, Johannes M. F. G. Aerts, Jon D. Laman

    I whakaputaina 2004
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Cardiac Fabry Disease With Late Gadolinium Enhancement Is a Chronic Inflammatory Cardiomyopathy

    Cardiac Fabry Disease With Late Gadolinium Enhancement Is a Chronic Inflammatory Cardiomyopathy mā Sabrina Nordin, Rebecca Kozor, Heerajnarain Bulluck, Silvia Castelletti, Stefania Rosmini, Amna Abdel‐Gadir, Shanat Baig, Atul Mehta, Derralynn Hughes, James Moon

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease

    Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease mā Daniel G. Bichet, Johannes M. F. G. Aerts, Christiane Auray‐Blais, Hiroki Maruyama, Atul Mehta, Nina Skuban, Eva Krusinska, Raphael Schiffmann

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Gaucher Cells Demonstrate a Distinct Macrophage Phenotype and Resemble Alternatively Activated Macrophages

    Gaucher Cells Demonstrate a Distinct Macrophage Phenotype and Resemble Alternatively Activated Macrophages mā Leonie A. Boven, Marjan van Meurs, Rolf G. Boot, Atul Mehta, Louis Boon, Johannes M. F. G. Aerts, Jon D. Laman

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis

    Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis mā Michael Beck, Derralynn Hughes, Christoph Kampmann, Sylvain Larroque, Atul Mehta, Guillem Pintos‐Morell, Uma Ramaswami, Michael L. West, Anna Wijatyk, Roberto Giugliani

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: